Association of TMPRSS6 polymorphisms with ferritin, hemoglobin, and type 2 diabetes risk in a Chinese Han population

American Journal of Clinical Nutrition

Volumn 95, Issue 3, 2012, Pages 626-632

  Gan, Wei ^a   Guan, Yu ^a,b   Wu, Qian ^a   An, Peng ^a   Zhu, Jingwen ^a   Lu, Ling ^a   Jing, Li ^a   Yu, Yu ^a   Ruan, Sheng ^c   Xie, Dong ^a   Makrides, Maria ^d   Gibson, Robert A ^e   Anderson, Gregory J ^f   Li, Huaixing ^a   Lin, Xu ^a   Wang, Fudi ^a  

^a Chinese Academy of Sciences   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c Bijie Renmin Hospital   (China)

^d WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^e UNIVERSITY OF ADELAIDE   (Australia)

^f ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE; GENETIC POLYMORPHISM; HUMAN; IRON OVERLOAD; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSMEMBRANE PROTEASE SERINE 6 GENE;

ALLELES; ANTIMICROBIAL CATIONIC PEPTIDES; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FERRITINS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HEMOGLOBINS; HOMEOSTASIS; HUMANS; IRON; LINEAR MODELS; MALE; MEMBRANE PROTEINS; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SERINE ENDOPEPTIDASES;

EID: 84863229728     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.111.025684     Document Type: Article

References (46)

1. Andrews NC. Iron metabolism: iron deficiency and iron overload. Annu Rev Genomics Hum Genet 2000;1:75-98 .
2. Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of mammalian iron metabolism. Cell 2010;142:24-38 .
3. De Domenico I, McVey Ward D, Kaplan J. Regulation of iron acquisition and storage: consequences for iron-linked disorders. Nat Rev Mol Cell Biol 2008;9:72-81.
4. Schadt EE, Molony C, Chudin E, Hao K, Yang X, Lum PY, Kasarskis A, Zhang B, Wang S, Suver C, et al. Mapping the genetic architecture of gene expression in human liver. PLoS Biol 2008;6:e107.
5. World Health Organization. Assessing the iron status of populations. 2nd ed. Geneva, Switzerland: WHO Press, 2007.
6. Whitfield JB, Cullen LM, Jazwinska EC, Powell LW, Heath AC, Zhu G, Duffy DL, Martin NG. Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. Am J Hum Genet 2000;66:1246-58. (Pubitemid 30468782)
7. Njajou OT, Alizadeh BZ, Aulchenko Y, Zillikens MC, Pols HA, Oostra BA, Swinkels DW, van Duijn CM. Heritability of serum iron, ferritin and transferrin saturation in a genetically isolated population, the Erasmus Rucphen Family (ERF) Study. Hum Hered 2006;61:222-8. (Pubitemid 44357219)
8. Pilia G, Chen WM, Scuteri A, Orru M, Albai G, Dei M, Lai S, Usala G, Lai M, Loi P, et al. Heritability of cardiovascular and personality traits in 6,148 Sardinians. PLoS Genet 2006;2:e132.
9. Marroni F, Grazio D, Pattaro C, Devoto M, Pramstaller P. Estimates of genetic and environmental contribution to 43 quantitative traits support sharing of a homogeneous environment in an isolated population from South Tyrol, Italy. Hum Hered 2008;65:175-82. (Pubitemid 350253957)
10. Acton RT, Barton JC, Passmore LV, Adams PC, Speechley MR, Dawkins FW, Sholinsky P, Reboussin DM, McLaren GD, Harris EL, et al. Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study. Diabetes Care 2006;29:2084-9. (Pubitemid 44871191)
11. Utzschneider KM, Kowdley KV. Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice. Nat Rev Endocrinol 2010;6:26-33.
12. Franchini M, Montagnana M, Lippi G. Hepcidin and iron metabolism: from laboratory to clinical implications. Clin Chim Acta 2010;411(21-22):1565-9.
13. Du X, She E, Gelbart T, Truksa J, Lee P, Xia Y, Khovananth K, Mudd S, Mann N, Moresco EM, et al. The serine protease TMPRSS6 is required to sense iron deficiency. Science 2008;320:1088-92. (Pubitemid 351929552)
14. Folgueras AR, de Lara FM, Pendas AM, Garabaya C, Rodriguez F, Astudillo A, Bernal T, Cabanillas R, Lopez-Otin C, Velasco G. Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis. Blood 2008;112:2539-45.
15. Silvestri L, Pagani A, Nai A, De Domenico I, Kaplan J, Camaschella C. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab 2008;8:502-11.
16. Altamura S, D'Alessio F, Selle B, Muckenthaler MU. A novel TMPRSS6 mutation that prevents protease auto-activation causes IRIDA. Biochem J 2010;431:363-71.
17. Beutler E, Van Geet C, te Loo DM, Gelbart T, Crain K, Truksa J, Lee PL. Polymorphisms and mutations of human TMPRSS6 in iron deficiency anemia. Blood Cells Mol Dis 2010;44:16-21.
18. De Falco L, Totaro F, Nai A, Pagani A, Girelli D, Silvestri L, Piscopo C, Campostrini N, Dufour C, Al Manjomi F, et al. Novel TMPRSS6 mutations associated with iron-refractory iron deficiency anemia (IRIDA). Hum Mutat 2010;31:E1390-405.
19. Delbini P, Vaja V, Graziadei G, Duca L, Nava I, Refaldi C, Cappellini MD. Genetic variability of TMPRSS6 and its association with iron deficiency anaemia. Br J Haematol 2010;151:281-4.
20. Isabelle T, Marguerite NA, Photis B. Cryptic splice site usage leading to truncated TMPRSS6 is responsible for iron refractory iron deficiency anaemia in an Italian Family. Eur J Haematol 2011;86:178-.
21. Finberg KE, Heeney MM, Campagna DR, Aydinok Y, Pearson HA, Hartman KR, Mayo MM, Samuel SM, Strouse JJ, Markianos K, et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet 2008;40:569-71. (Pubitemid 351601217)
22. Melis MA, Cau M, Congiu R, Sole G, Barella S, Cao A, Westerman M, Cazzola M, Galanello R. A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron. Haematologica 2008;93:1473-9.
23. Edison ES, Athiyarath R, Rajasekar T, Westerman M, Srivastava A, Chandy M. A novel splice site mutation c.2278 (-1) G.C in the TMPRSS6 gene causes deletion of the substrate binding site of the serine protease resulting in refractory iron deficiency anaemia. Br J Haematol 2009;147:766-9.
24. Silvestri L, Guillem F, Pagani A, Nai A, Oudin C, Silva M, Toutain F, Kannengiesser C, Beaumont C, Camaschella C, et al. Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia. Blood 2009;113:5605-8.
25. Guillem F, Lawson S, Kannengiesser C, Westerman M, Beaumont C, Grandchamp B. Two nonsense mutations in the TMPRSS6 gene in a patient with microcytic anemia and iron deficiency. Blood 2008;112: 2089-91.
26. Benyamin B, Ferreira MA, Willemsen G, Gordon S, Middelberg RP, McEvoy BP, Hottenga JJ, Henders AK, Campbell MJ, Wallace L, et al. Common variants in TMPRSS6 are associated with iron status and erythrocyte volume. Nat Genet 2009;41:1173-5.
27. Chambers JC, ZhangW, Li Y, Sehmi J, Wass MN, Zabaneh D, Hoggart C, Bayele H, McCarthy MI, Peltonen L, et al. Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels. Nat Genet 2009;41:1170-2.
28. Ganesh SK, Zakai NA, van Rooij FJ, Soranzo N, Smith AV, Nalls MA, Chen MH, Kottgen A, Glazer NL, Dehghan A, et al. Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet 2009;41:1191-8.
29. Soranzo N, Spector TD, Mangino M, Kuhnel B, Rendon A, Teumer A, Willenborg C, Wright B, Chen L, Li M, et al. A genome-wide meta- analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet 2009;41:1182-90.
30. Tanaka T, Roy CN, Yao W, Matteini A, Semba RD, Arking D, Walston JD, Fried LP, Singleton A, Guralnik J, et al. A genome-wide association analysis of serum iron concentrations. Blood 2010;115:94-6.
31. Pichler I, Minelli C, Sanna S, Tanaka T, Schwienbacher C, Naitza S, Porcu E, Pattaro C, Busonero F, Zanon A, et al. Identification of a common variant in the TFR2 gene implicated in the physiological regulation of serum iron levels. Hum Mol Genet 2011; 20(6):1232-40.
32. Liu Q, Sun L, Tan Y, Wang G, Lin X, Cai L. Role of iron deficiency and overload in the pathogenesis of diabetes and diabetic complications. Curr Med Chem 2009;16:113-29.
33. Sun L, Franco OH, Hu FB, Cai L, Yu Z, Li H, Ye X, Qi Q, Wang J, Pan A, et al. Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly chinese. J Clin Endocrinol Metab 2008;93:4690-6.
34. Ye X, Yu Z, Li H, Franco OH, Liu Y, Lin X. Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. J Am Coll Cardiol 2007;49:1798-805. (Pubitemid 46629126)
35. Wu Y, Li H, Loos RJ, Yu Z, Ye X, Chen L, Pan A, Hu FB, Lin X. Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population. Diabetes 2008;57:2834-42.
36. World Health Organization/United Nations Children's Fund/United Nations University. Iron deficiency anaemia: assessment, prevention and control: a guide for programme managers. WHO/NHD/01.3. Geneva, Switzerland: World Health Organization, 2001.
37. Laura-Lee Boodram. Department of Life Sciences. The University of the West Indies. Internet: http://www.protocol-online.org/prot/Protocols/ Extraction-of-genomic-DNA-from-whole-blood-3171.html (cited 7 January 2011).
38. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5 (Pubitemid 40202029)
39. Centre for Genetic Epidemiology and Biostatistics. The University of Western Australia. Available from: http://www.genepi.meddent.uwa. edu.au/software/simhap (cited October 2010).
40. Software R. Available from: http://www.r-project.org. Version 2.7.0 (cited 7 January 2011).
41. Lee P. Role of matriptase-2 (TMPRSS6) in iron metabolism. Acta Haematol 2009;122:87-96.
42. Kim CH, Kim HK, Bae SJ, Park JY, Lee KU. Association of elevated serum ferritin concentration with insulin resistance and impaired glucose metabolism in Korean men and women. Metabolism 2011;60:414-20.
43. Ascherio A, Rimm EB, Giovannucci E, Willett WC, Stampfer MJ. Blood donations and risk of coronary heart disease in men. Circulation 2001;103:52-7. (Pubitemid 32050435)
44. Cutler P. Deferoxamine therapy in high-ferritin diabetes. Diabetes 1989;38:1207-10. (Pubitemid 19247413)
45. Fernández-Real JM, Penarroja G, Castro A, Garcia-Bragado F, Hernandez- Aguado I, Ricart W. Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function. Diabetes 2002;51:1000-4. (Pubitemid 34438342)
46. Finberg KE, Whittlesey RL, Andrews NC. Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice. Blood 2011;117:4590-9.